Skip to main content
Article
Neoadjuvant chemoradiation for resectable and borderline resectable pancreatic cancer: is there a benefit?
Digestive Medicine Research (2020)
  • Michael D. Chuong
  • Leila T. Tchelebi
  • Richard Tuli
Publication Date
May 22, 2020
DOI
10.21037/DMR-20-41
Citation Information
Michael D. Chuong, Leila T. Tchelebi and Richard Tuli. "Neoadjuvant chemoradiation for resectable and borderline resectable pancreatic cancer: is there a benefit?" Digestive Medicine Research Vol. 3 (2020) p. 105 - 105
Available at: http://works.bepress.com/michael-chuong/132/